News
-
Does free food from med reps influence medics to prescribe ?
over 7 years ago by Gerry Kennedy
The Journal of the American Medical Association lit a fuse in pharma last week with its study of free meals for doctors--the one that associated pharma’s food with increases in brand prescriptions. Since it published 8 days ago, we’ve seen an explosion of response from industry executives and marketing experts alike. So, we turned to someone ...
Read More -
EMA needs to move......................Dublin ?
over 7 years ago by Gerry Kennedy
The European Medicines Agency, the drug regulator for Europe, is headquartered in London. The problem is that the U.K. voted Thursday to leave the European Union, meaning the EMA will now have to leave and find a new home. It is one of the countless concerns that affect the pharma industry with Britain’s historic vote to give up on European unit...
Read More -
Brexit impact on life sciences
over 7 years ago by Gerry Kennedy
As U.K. voters head to the polls on Thursday for the EU referendum, uncertainty for life sciences looms large. FierceBiotech talks to biotech execs, regulators and trade groups to assess the mood ahead of Thursday’s vote. The road to a referendum has been a relatively short one; official campaigning to remain in the EU or leave the Union bega...
Read More -
Trump or Clinton ? which candidates will best serve big pharma's interest ?
almost 8 years ago by Gerry Kennedy
Which presidential candidate will best serve Big Pharma’s interests? Pfizer chief Ian Read has thought about it--and he honestly can’t figure it out. Read can’t “at this moment distinguish between the policies that Donald Trump may support or those that Hillary Clinton may support,” he said at last week’s Sanford Bernstein Strategic Decis...
Read More -
Jazz acquires Celator in $1.5 billion deal
almost 8 years ago by Gerry Kennedy
The Wall Street Journal kicked off rumors over the Memorial Day weekend that Ireland’s Jazz Pharmaceuticals ($JAZZ) was set to buy Celator ($CPXX), and early this morning, the two confirmed the $1.5 billion deal was to go ahead. Jazz Pharmaceuticals said it will acquire Celator for $30.25 per share in cash--making the deal worth a total of $1...
Read More